Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, An Issue of Interventional Cardiology Clinics, 1st Edition
Author :
Luis Ortega Paz
Date of Publication: 09/2024
In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top ...view more
In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.
In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.
Key Features
Contains 13 relevant, practice-oriented topics including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more.
Provides in-depth clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.mea.elsevierhealth.com/antiplatelet-and-anticoagulation-therapy-in-cardiovascular-and-pulmonary-embolism-transcatheter-interventions-an-issue-of-interventional-cardiology-clinics-9780443296727.html314222Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, An Issue of Interventional Cardiology Clinicshttps://www.mea.elsevierhealth.com/media/catalog/product/9/7/9780443296727_7.jpg62.0968.99USDInStock/Medicine and Surgery/Cardiology/Clinics Review Articles99275612838In this issue of <i>Interventional Cardiology Clinics</i>, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of <b>Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions</b>. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y<sub>12</sub> inhibitors and clinical implications; switching P2Y<sub>12</sub> receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more. In this issue of <i>Interventional Cardiology Clinics</i>, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of <b>Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions</b>. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y<sub>12</sub> inhibitors and clinical implications; switching P2Y<sub>12</sub> receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.USD00add-to-cart97804432967272024ProfessionalBy 20241Book178w x 254h (7.00" x 10.00")Elsevier24012 Sept 2024PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG></STRONG>ClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
